PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase

Rebecca J. Chan, Gen Sheng Feng

Research output: Contribution to journalReview article

199 Scopus citations

Abstract

Elucidation of the molecular mechanisms underlying carcinogenesis has benefited tremendously from the identification and characterization of oncogenes and tumor suppressor genes. One new advance in this field is the identification of PTPN11 as the first proto-oncogene that encodes a cytoplasmic tyrosine phosphatase with 2 Src-homology 2 (SH2) domains (Shp2). This tyrosine phosphatase was previously shown to play an essential role in normal hematopoiesis. More recently, somatic missense PTPN11 gain-of-function mutations have been detected in leukemias and rarely in solid tumors, and have been found to induce aberrant hyperactivation of the Ras-Erk pathway. This progress represents another milestone in the leukemia/cancer research field and provides a fresh view on the molecular mechanisms underlying cell transformation.

Original languageEnglish (US)
Pages (from-to)862-867
Number of pages6
JournalBlood
Volume109
Issue number3
DOIs
StatePublished - Feb 1 2007

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase'. Together they form a unique fingerprint.

  • Cite this